| 000 | 03307nam a22003495i 4500 | ||
|---|---|---|---|
| 001 | 82668 | ||
| 003 | ES-MaUEC | ||
| 005 | 20230207040419.0 | ||
| 008 | 160720t2015 ne a s |||| 0|eng d | ||
| 020 | _a9789401792141 | ||
| 040 | _aES-MaUEC | ||
| 050 | 4 |
_aRC48.8 _b2015 EB |
|
| 082 | 0 | 4 | _a570.28 |
| 245 | 0 | 0 |
_aRare diseases : _bintegrative PPPM approach as the medicine of the future _cedited by Meral Özgüç |
| 260 |
_aDordrecht _bSpringer _ccop. 2015 |
||
| 300 |
_a1 recurso en línea (XVIII, 208 p.) _bil. |
||
| 336 |
_aTexto (visual) _btxt _2rdacontent |
||
| 337 |
_aelectrónico _bc _2rdamedia |
||
| 338 |
_arecurso electrónico _bcr _2rdacarrier |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 |
_aAdvances in Predictive, Preventive and Personalised Medicine _x2211-3495 _v6 |
|
| 520 | _aThis book focuses on predictive, preventative and personalised medicine (PPPM) and how it is related to the healthcare of rare diseases. Readers will discover how advanced rare diseases healthcare provides an excellent “proof-of-principlesâ€{u09AF}r the personalisation of healthcare systems on a global scale. Chapters look at national plans for rare disease, at biobanking, gene identification, rare cancers, virus gene therapy , induced pluripotency for cell therapy amongstÂ{u0BF4}her topics. There is a chapter dedicated to personalised medicine for hereditary deafness, and another exploring the complexity of genotype-phenotype correlations. Specific diseases such as Fabry's, Gauchers and mitochondrial cytopathies are highlighted and we look at enzyme replacement therapy in lysosomal storage diseases. This work is part of a series, produced with the involvement of the European Association for Predictive, Preventive and Personalised Medicine. The series focusses on the concept of an integrative medical approach by PPPM. This volume is dedicated to all aspects related to the prediction, prevention and personalised treatments of rare diseases, and in doing so it explores developments relevant to all medical branches. The authors cover ethical considerations, the creation of a robust platform for professional communication, synergies with patient organisations, “doctor-patientâ€{u08EF}llaboration and a new philosophy of integrative medicine by PPPM. This volume serves as a reference source for scientific and medical centres in the field and can be used both at medical curricula and graduate level in the life sciences. Those who place a special emphasis on healthcare promotion and innovations intended to combat rare diseases, save the affected lives and enhance life quality will all find this book of great value | ||
| 942 |
_2lcc _cLE |
||
| 650 | 7 |
_aEnfermedades raras _9160812 _0comprobar BNE20022680411 _2embne |
|
| 856 | 4 | 0 |
_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://link.springer.com/book/10.1007/978-94-017-9214-1 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid) |
| 901 | _ai9789401792141 | ||
| 907 |
_a.b1291308x _b10-10-17 _c10-02-16 |
||
| 988 | _aSpringer_Medicine_2015 | ||
| 998 |
_am _a_alco _a_vill _b20-07-16 _cm _dz _ea _feng _gne _h0 |
||
| 945 |
_aRC48.8 .R37 2015 EB _g1 _ieBOOK _j0 _lmae _o- _pEUR0.00 _q- _r- _sb _t15 _u0 _v0 _w0 _x0 _y.i11580768 _z06-04-17 |
||
| 999 |
_c82668 _d82668 _x1 |
||